Gregory D. Davis, Head of Research & Technology at SANGAMO THERAPEUTICS, INC (SGMO), sold 69,827 shares at $0.25 ($18K) on 2026-04-22, disclosed to the SEC on 2026-04-23.
Open-market sale of $18k SGMO by Head of Research & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.